<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>122(6)</volume><submitter>Felcht M</submitter><pubmed_abstract>Angiopoietin-2 (ANG-2) is a key regulator of angiogenesis that exerts context-dependent effects on ECs. ANG-2 binds the endothelial-specific receptor tyrosine kinase 2 (TIE2) and acts as a negative regulator of ANG-1/TIE2 signaling during angiogenesis, thereby controlling the responsiveness of ECs to exogenous cytokines. Recent data from tumors indicate that under certain conditions ANG-2 can also promote angiogenesis. However, the molecular mechanisms of dual ANG-2 functions are poorly understood. Here, we identify a model for the opposing roles of ANG-2 in angiogenesis. We found that angiogenesis-activated endothelium harbored a subpopulation of TIE2-negative ECs (TIE2lo). TIE2 expression was downregulated in angiogenic ECs, which abundantly expressed several integrins. ANG-2 bound to th</pubmed_abstract><journal>The Journal of clinical investigation</journal><pagination>1991-2005</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3366398</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.</pubmed_title><pmcid>PMC3366398</pmcid><pubmed_authors>Besemfelder E</pubmed_authors><pubmed_authors>Chavakis E</pubmed_authors><pubmed_authors>Kutschera S</pubmed_authors><pubmed_authors>Schering A</pubmed_authors><pubmed_authors>Vettel C</pubmed_authors><pubmed_authors>Kienast Y</pubmed_authors><pubmed_authors>Loos EK</pubmed_authors><pubmed_authors>Luck R</pubmed_authors><pubmed_authors>Terhardt D</pubmed_authors><pubmed_authors>Goerdt S</pubmed_authors><pubmed_authors>Bartels S</pubmed_authors><pubmed_authors>Seidel P</pubmed_authors><pubmed_authors>Klein C</pubmed_authors><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Appak S</pubmed_authors><pubmed_authors>Bartol A</pubmed_authors><pubmed_authors>Uemura A</pubmed_authors><pubmed_authors>Felcht M</pubmed_authors><pubmed_authors>Srivastava K</pubmed_authors><pubmed_authors>Wieland T</pubmed_authors><pubmed_authors>Augustin HG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.</name><description>Angiopoietin-2 (ANG-2) is a key regulator of angiogenesis that exerts context-dependent effects on ECs. ANG-2 binds the endothelial-specific receptor tyrosine kinase 2 (TIE2) and acts as a negative regulator of ANG-1/TIE2 signaling during angiogenesis, thereby controlling the responsiveness of ECs to exogenous cytokines. Recent data from tumors indicate that under certain conditions ANG-2 can also promote angiogenesis. However, the molecular mechanisms of dual ANG-2 functions are poorly understood. Here, we identify a model for the opposing roles of ANG-2 in angiogenesis. We found that angiogenesis-activated endothelium harbored a subpopulation of TIE2-negative ECs (TIE2lo). TIE2 expression was downregulated in angiogenic ECs, which abundantly expressed several integrins. ANG-2 bound to th</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jun</publication><modification>2025-04-03T22:33:47.57Z</modification><creation>2019-03-27T00:54:07Z</creation></dates><accession>S-EPMC3366398</accession><cross_references><pubmed>22585576</pubmed><doi>10.1172/JCI58832</doi><doi>10.1172/jci58832</doi></cross_references></HashMap>